Table 3. Celiac risk variants correlated with cis gene expression.
SNPa | Chr | SNP positionb | Probe Centre Positionb |
Illumina ArrayAddressID |
Expression datasetc |
Gene name | eQTL P valued |
---|---|---|---|---|---|---|---|
Loci with genome-wide significant evidence (Pcombined <5 × 10−8) | |||||||
rs3748816 | 1 | 2516606 | 2412221 | 650452 | HT-12 | PLCH2 | 1.66 × 10−5 |
rs3748816 | 1 | 2516606 | 2482955 | 6520725 | Ref-8v2 + HT-12 | TNFRSF14 | 1.30 × 10−3 |
rs3748816 | 1 | 2516606 | 2510429 | 6250338 | Ref-8v2 | C1orf93 | 1.16 × 10−4 |
rs3748816 | 1 | 2516606 | 2533115 | 2070246 | Ref-8v2 + HT-12 | MMEL1 | 1.03 × 10−20 |
rs296547 | 1 | 199158760 | 198880146 | 1300279 | Ref-8v2 + HT-12 | DDX59 | 2.45 × 10−5 |
rs842647 | 2 | 60972975 | 61263810 | 1170220 | Ref-8v2 + HT-12 | AHSA2 | 3.30 × 10−10 |
rs13003464e | 2 | 61040333 | 61263810 | 1170220 | Ref-8v2 + HT-12 | AHSA2 | 6.39 × 10−11 |
rs3816281f | 2 | 68461451 | 68461957 | 4810020 | Ref-8v2 + HT-12 | PLEK | 7.97 × 10−26 |
rs917997 | 2 | 102437000 | 102418571 | 6520180 | Ref-8v2 + HT-12 | IL18RAP | 7.35 × 10−87 |
rs13010713 | 2 | 181704290 | 181593865 | 1780433 | HT-12 | UBE2E3 | 4.93 × 10−5 |
rs13098911 | 3 | 46210205 | 45964449 | 6550333 | Ref-8v2 + HT-12 | CXCR6 | 9.66 × 10−6 |
rs13098911 | 3 | 46210205 | 46255176g | 2190671 | HT-12 | CCR3 | 5.50 × 10−10 |
rs13098911 | 3 | 46210205 | 46255176g | 7570670 | Ref-8v2 | CCR3 | 5.69 × 10−4 |
rs6441961d | 3 | 46327388 | 46255176h | 2190671 | HT-12 | CCR3 | 2.87 × 10−19 |
rs6441961d | 3 | 46327388 | 46255176h | 7570670 | Ref-8v2 | CCR3 | 1.02 × 10−4 |
rs11922594f | 3 | 120608512 | 120683364i | 6550288 | Ref-8v2 + HT-12 | KTELC1 | 5.09 × 10−17 |
rs11922594f | 3 | 120608512 | 120683364i | 3850161 | Ref-8v2 + HT-12 | KTELC1 | 7.34 × 10−6 |
rs10806425 | 6 | 90983333 | 90878075 | 3520349 | HT-12 | BACH2 | 1.92 × 10−3 |
rs1738074 | 6 | 159385965 | 159380068 | 5890739 | Ref-8v2 + HT-12 | TAGAP | 1.99 × 10−3 |
rs1738074 | 6 | 159385965 | 159381094 j | 5360364 | HT-12 | TAGAP | 3.23 × 10−4 |
rs1738074 | 6 | 159385965 | 159381094 j | 4860242 | HT-12 | TAGAP | 2.18 × 10−3 |
rs1250552 | 10 | 80728033 | 80622540 | 2450131 | Ref-8v2 + HT-12 | ZMIZ1 | 1.80 × 10−3 |
rs653178 | 12 | 110492139 | 110399552 | 6560301 | Ref-8v2 + HT-12 | SH2B3 | 9.24 × 10−12 |
rs653178 | 12 | 110492139 | 110710447 | 840253 | Ref-8v2 + HT-12 | ALDH2 | 1.44 × 10−4 |
rs653178 | 12 | 110492139 | 110894406 k | 2070736 | HT-12 | TMEM116 | 3.68 × 10−4 |
rs653178 | 12 | 110492139 | 110894406 k | 3190129 | Ref-8v2 | TMEM116 | 1.51 × 10−3 |
rs12928822 | 16 | 11311394 | 11335627 | 4540072 | Ref-8v2 + HT-12 | C16orf75 | 1.02 × 10−8 |
rs4819388 | 21 | 44471849 | 44049567 | 7200373 | Ref-8v2 | RRP1 | 2.62 × 10−3 |
Loci with suggestive evidence (either A. 10−6>Pcombined>5×10−8 and/or B. PGWAS<10−4 and Pfollow-up<0.01) | |||||||
rs12727642 | 1 | 7969259 | 7956138 | 610193 | Ref-8v2 + HT-12 | PARK7 | 9.76 × 10−15 |
rs864537 | 1 | 165678008 | 165710482 l | 6290400 | Ref-8v2 + HT-12 | CD247 | 1.77 × 10−9 |
rs864537 | 1 | 165678008 | 165710482 l | 3890689 | HT-12 | CD247 | 2.93 × 10−7 |
rs6974491 | 7 | 37341035 | 37157761 | 2750154 | Ref-8v2 + HT-12 | ELMO1 | 5.40 × 10−6 |
rs2074404 | 17 | 42220599 | 41824345 | 3520672 | Ref-8v2 + HT-12 | LRRC37A | 1.17 × 10−4 |
rs2074404 | 17 | 42220599 | 42106695 m | 5260138 | Ref-8v2 + HT-12 | NSF | 1.20 × 10−5 |
rs2074404 | 17 | 42220599 | 42106695 m | 1410484 | HT-12 | NSF | 4.28 × 10−4 |
rs2074404 | 17 | 42220599 | 42223012 | 4070615 | HT-12 | WNT3 | 2.77 × 10−3 |
rs2074404 | 17 | 42220599 | 42485154 | 4880037 | HT-12 | LOC388397 | 1.78 × 10−9 |
rs2298428 | 22 | 20312892 | 20308188 | 1230242 | Ref-8v2 + HT-12 | UBE2L3 | 1.96 × 10−90 |
rs5979785 | X | 12881445 | 12842944 n | 6480360 | Ref-8v2 + HT-12 | TLR8 | 3.88 × 10−13 |
rs5979785 | X | 12881445 | 12842944 n | 3390612 | Ref-8v2 + HT-12 | TLR8 | 1.07 × 10−7 |
See Supplementary Figures 2 & 3 for detailed results, and Supplementary Table 3 for more detail of Illumina expression probes.
We tested the SNP with the strongest association from 34 of 39 non-HLA loci (Pcombined<10−6, Table 2), Hap300 proxy SNPs for 4 further loci, and a second independently associated SNP from 6 loci, for correlation with gene expression in PAXgene blood RNA in up to 1,349 individuals. 1 locus (containing ETS1) where an adequate proxy SNP was not available was not included for the eQTL analysis. SNP-gene expression correlations were tested for probes within a 1Mb window. Results are presented for SNPs showing significant correlations with cis gene expression after controlling false discovery rate at 5% (corresponding to P<0.0028).
All chromosomal positions are based on NCBI build-36 coordinates. Probe centre position was determined by re-mapping probe sequences to the human transcriptome and calculated from the mid-point of the transcript start and transcript end positions in genomic co-ordinates.
‘HT-12’ comprise 1240 individuals with blood gene expression assayed using Illumina Human HT-12v3 arrays, ‘Ref-8v2’ comprise 229 individuals with blood gene expression assayed using Illumina Human-Ref-8v2 arrays (Online Methods).
Spearman rank correlation of genotype and residual variance in transcript expression. Meta-analysis eQTL P value shown if both datasets had identical probes.
Second, independently associated SNP from this locus.
Proxy SNP, r2=0.61 in HapMap CEU with most associated SNP rs11712165.
Different Illumina probe sequences with the same Probe Centre Position.
Different Illumina probe sequences with the same Probe Centre Position.
Different Illumina probe sequences with the same Probe Centre Position.
Different Illumina probe sequences with the same Probe Centre Position.
Different Illumina probe sequences with the same Probe Centre Position.
Different Illumina probe sequences with the same Probe Centre Position.
Different Illumina probe sequences with the same Probe Centre Position.
Different Illumina probe sequences with the same Probe Centre Position.